Alexandre Morizot

1.8k total citations
19 papers, 1.4k citations indexed

About

Alexandre Morizot is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Alexandre Morizot has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Alexandre Morizot's work include Cell death mechanisms and regulation (12 papers), NF-κB Signaling Pathways (8 papers) and interferon and immune responses (7 papers). Alexandre Morizot is often cited by papers focused on Cell death mechanisms and regulation (12 papers), NF-κB Signaling Pathways (8 papers) and interferon and immune responses (7 papers). Alexandre Morizot collaborates with scholars based in France, Canada and United States. Alexandre Morizot's co-authors include Olivier Micheau, Najoua Lalaoui, Éric Solary, Delphine Mérino, Maya Saleh, Claudia Champagne, Jeremy Dupaul-Chicoine, Maryse Dagenais, Todd Douglas and Pascal Schneider and has published in prestigious journals such as Immunity, The Journal of Immunology and PLoS ONE.

In The Last Decade

Alexandre Morizot

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Morizot France 17 1.0k 655 302 217 184 19 1.4k
Ramesh B. Batchu United States 25 1.0k 1.0× 415 0.6× 446 1.5× 199 0.9× 137 0.7× 55 1.7k
Feifei Xu China 24 1.2k 1.1× 395 0.6× 362 1.2× 352 1.6× 121 0.7× 76 1.8k
Clark A. Sehon United States 14 1.3k 1.3× 739 1.1× 213 0.7× 196 0.9× 250 1.4× 18 2.3k
Xiaofei Yu United States 22 656 0.6× 708 1.1× 257 0.9× 154 0.7× 144 0.8× 41 1.4k
Mohamed Amessou France 17 746 0.7× 345 0.5× 352 1.2× 133 0.6× 146 0.8× 33 1.6k
Tâm Nguyễn United States 17 942 0.9× 391 0.6× 258 0.9× 274 1.3× 138 0.8× 32 1.3k
Arvinder Kapur United States 20 862 0.8× 531 0.8× 333 1.1× 263 1.2× 81 0.4× 39 1.6k
Pierre Beauparlant Canada 16 874 0.9× 495 0.8× 329 1.1× 394 1.8× 196 1.1× 25 1.6k
Magdalena Klink Poland 18 456 0.4× 456 0.7× 244 0.8× 166 0.8× 94 0.5× 73 1.2k
Robert W. Marquis United States 19 1.9k 1.9× 732 1.1× 429 1.4× 319 1.5× 269 1.5× 30 2.5k

Countries citing papers authored by Alexandre Morizot

Since Specialization
Citations

This map shows the geographic impact of Alexandre Morizot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Morizot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Morizot more than expected).

Fields of papers citing papers by Alexandre Morizot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Morizot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Morizot. The network helps show where Alexandre Morizot may publish in the future.

Co-authorship network of co-authors of Alexandre Morizot

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Morizot. A scholar is included among the top collaborators of Alexandre Morizot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Morizot. Alexandre Morizot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dagenais, Maryse, Jeremy Dupaul-Chicoine, Todd Douglas, et al.. (2017). The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis. OncoImmunology. 6(3). e1287247–e1287247. 47 indexed citations
2.
Iessi, Elisabetta, Aymeric Morlé, Guillaume Jacquemin, et al.. (2015). Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells. PLoS ONE. 10(5). e0126526–e0126526. 11 indexed citations
3.
Dagenais, Maryse, Jeremy Dupaul-Chicoine, Claudia Champagne, et al.. (2015). A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways. Mucosal Immunology. 9(1). 146–158. 16 indexed citations
4.
Douglas, Todd, Claudia Champagne, Alexandre Morizot, Jean‐Martin Lapointe, & Maya Saleh. (2015). The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice. The Journal of Immunology. 195(5). 2365–2373. 63 indexed citations
5.
Dupaul-Chicoine, Jeremy, Azadeh Arabzadeh, Maryse Dagenais, et al.. (2015). The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity. Immunity. 43(4). 751–763. 271 indexed citations
6.
Skeldon, Alexander, Alexandre Morizot, Todd Douglas, et al.. (2015). Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance. The Journal of Immunology. 196(1). 437–447. 18 indexed citations
7.
Rodrigue‐Gervais, Ian Gaël, Katherine Labbè, Maryse Dagenais, et al.. (2014). Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival. Cell Host & Microbe. 15(1). 23–35. 132 indexed citations
8.
Marivin, Arthur, Jean Berthelet, Jessy Cartier, et al.. (2013). cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation. Oncogene. 33(48). 5534–5545. 20 indexed citations
9.
Morizot, Alexandre & Maya Saleh. (2012). Non-apoptotic functions of cell death effectors in inflammation and innate immunity. Microbes and Infection. 14(14). 1241–1253. 4 indexed citations
10.
Somasekharan, Syam Prakash, Michal Koc, Alexandre Morizot, et al.. (2012). TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis. APOPTOSIS. 18(3). 324–336. 24 indexed citations
11.
Jacquemin, G., V. Granci, Anne-Sophie Gallouët, et al.. (2011). Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. Haematologica. 97(1). 38–46. 71 indexed citations
12.
Lalaoui, Najoua, Aymeric Morlé, Delphine Mérino, et al.. (2011). TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT. PLoS ONE. 6(5). e19679–e19679. 55 indexed citations
13.
Shirley, Sarah, Alexandre Morizot, & Olivier Micheau. (2011). Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion. Recent Patents on Anti-Cancer Drug Discovery. 6(3). 311–323. 51 indexed citations
14.
Pavet, Valeria, Julien Beyrath, Christophe Pardin, et al.. (2010). Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity. Cancer Research. 70(3). 1101–1110. 89 indexed citations
15.
Fraszczak, Jennifer, Malika Trad, Nona Janikashvili, et al.. (2010). Peroxynitrite-Dependent Killing of Cancer Cells and Presentation of Released Tumor Antigens by Activated Dendritic Cells. The Journal of Immunology. 184(4). 1876–1884. 57 indexed citations
16.
Morizot, Alexandre, Delphine Mérino, Najoua Lalaoui, et al.. (2010). Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level. Cell Death and Differentiation. 18(4). 700–711. 65 indexed citations
17.
Travert, Marion, Patricia Amé-Thomas, Céline Pangault, et al.. (2008). CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-κB Activation and Up-Regulation of c-FLIP and Bcl-xL. The Journal of Immunology. 181(2). 1001–1011. 71 indexed citations
18.
Mérino, Delphine, Najoua Lalaoui, Alexandre Morizot, Éric Solary, & Olivier Micheau. (2007). TRAIL in cancer therapy: present and future challenges. Expert Opinion on Therapeutic Targets. 11(10). 1299–1314. 138 indexed citations
19.
Mérino, Delphine, Najoua Lalaoui, Alexandre Morizot, et al.. (2006). Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2. Molecular and Cellular Biology. 26(19). 7046–7055. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramesh B. Batchu Breakdown of academic impact, for papers by Feifei Xu Breakdown of academic impact, for papers by Clark A. Sehon Breakdown of academic impact, for papers by Xiaofei Yu Breakdown of academic impact, for papers by Mohamed Amessou Breakdown of academic impact, for papers by Tâm Nguyễn Breakdown of academic impact, for papers by Arvinder Kapur Breakdown of academic impact, for papers by Pierre Beauparlant Breakdown of academic impact, for papers by Magdalena Klink Breakdown of academic impact, for papers by Robert W. Marquis
Rankless by CCL
2026